Kinase inhibitors: An allosteric add-on

Nature Chemical Biology

Volumn 10, Issue 10, 2014, Pages 796-797

  Foda, Zachariah H ^a   Seeliger, Markus A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DORAMAPIMOD; IMATINIB; PHOSPHOTRANSFERASE INHIBITOR; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; INDAZOLE DERIVATIVE; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PIPERAZINE DERIVATIVE; SCH772984;

ALLOSTERISM; BINDING KINETICS; BINDING SITE; CHRONIC MYELOID LEUKEMIA; CONFORMATIONAL TRANSITION; IN VIVO STUDY; KINETICS; NOTE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN FUNCTION; SEQUENCE ALIGNMENT; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; HUMAN; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; ENZYME INHIBITORS; HUMANS; INDAZOLES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PIPERAZINES;

EID: 84922013883     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1630     Document Type: Note

References (10)

1. Jemal, A. et al. CA Cancer J. Clin. 57, 43-66 (2007).
2. Chaikuad, A. et al. Nat. Chem. Biol. doi:10.1038/nchembio.1629 (7 September 2014).
3. Morris, E.J. et al. Cancer Discov. 3, 742-750 (2013).
4. Zhang, J., Yang, P.L. & Gray, N.S. Nat. Rev. Cancer 9, 28-39 (2009).
5. Huse, M. & Kuriyan, J. Cell 109, 275-282 (2002).
6. Nussinov, R. & Tsai, C.J. Cell 153, 293-305 (2013).
7. Ohren, J.F. et al. Nat. Struct. Mol. Biol. 11, 1192-1197 (2004).
8. Regan, J. et al. Bioorg. Med. Chem. Lett. 13, 3101-3104 (2003).
9. Shan, Y. et al. Proc. Natl. Acad. Sci. USA 106, 139-144 (2009).
10. Lu, H. & Tonge, P.J. Curr. Opin. Chem. Biol. 14, 467-474 (2010).